Apellis Pharmaceuticals, Inc.
APLS
Revenue
199.91M
▼-258.67M▼-56.41%
3 Months ChangeAssets
1.08B
▲16.53M▲1.56%
3 Months ChangeLiabilities
705.11M
▲47.56M▲7.23%
3 Months ChangeFree Cash Flow
-53.42M
▲79.86M▲59.92%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001193125-26-084156
2026-01-12
Form 8-K
ID: 0001193125-26-010540
2025-10-30
Form 10-Q
ID: 0001193125-25-257374
2025-07-31
Form 10-Q
ID: 0000950170-25-100545
2025-07-01
Form 8-K
ID: 0001193125-25-153429
2025-06-04
Form 8-K
ID: 0001193125-25-134886
2025-05-07
Form 10-Q
ID: 0000950170-25-064976
2025-04-21
Form 8-K
ID: 0001193125-25-086304
2025-01-13
Form 8-K
ID: 0001193125-25-005052
2024-11-05
Form 10-Q
ID: 0000950170-24-121062